PhysiologybioRxiv
The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15
M. Stolina, X. Luo, D. Dwyer…·M. M. Veniant
This study characterizes an obese ZSF1 rat model of cardiometabolic syndrome and shows that GDF15 treatment reduces metabolic markers and improves cardiac function.
DOI 10.1371/journal.pone.0231234